中国医疗科技市场的增长战略_oct2014年.pdfVIP

A Strategy for Growth Medtech executives must have a firm understanding of these four concepts in order to achieve sustainable success in one of the world’s fastest-growing medical device markets China is synonymous with growth, The underlying growth drivers include setting a benchmark that’s increasingly the aging population, greater difficult to achieve in more mature affordability for care, changing lifestyles markets like those in the U.S. and and expanding healthcare coverage. In Europe. At the same time, China’s light of these numbers, it is folly for market is fraught with challenges executives at medtech companies not to ranging from anti-monopoly probes of expand on their China strategy. Key sub- automobile and technology companies to segments of China’s current medtech anti-bribery investigations of market include diagnostic imaging (38 pharmaceutical companies. It thus percent), consumables (16 percent) and becomes crucial for executives at patient aids (15 percent). multinationals to understand how to achieve sustainable growth while $bn* 49.42 navigating and mitigating potentially 50 high-impact business risks, which are 20% 41.14 universal for companies operating in 40 34.24 China regardless of their activities. 28.51 30 23.73 Similar to other industry spaces in China, the medical technology (medtech) 20 market offers incredible opportunity. Combinin